Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,749-2,760 of 4,306
Drug study icon
TerminatedNCT00548327

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00383747

The Effects of Nicotine on Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
Drug study icon
TerminatedNCT01874756

Selective Estrogen Receptor Beta Agonist for schizophrenia

This study was terminated in the United States. It is testing selective Estrogen Receptor Beta Agonist for schizophrenia.

In Indianapolis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
Drug study icon
CompletedNCT02142556

Quetiapine XR for schizophrenia

This study is completed in Taiwan. It is testing Quetiapine XR for schizophrenia.

In Taipei
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 65 Years
Countries
Taiwan
Sponsor
Tri-Service General Hospital (TSGH)
Condition
Schizophrenia
Drug study icon
CompletedNCT00034749

Risperidone for schizophrenia

This study is completed. It is testing risperidone for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02796417

The Efficacy of REHACOP Program in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Bilbao
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Spain
Sponsor
University of Deusto
Condition
Schizophrenia
Other study type icon
CompletedNCT00247637

The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.